for Human Health
Biostatira Research and Development Private Limited advances the frontier of diagnostic and therapeutic medical devices — combining rigorous biomedical science with precision engineering to deliver solutions clinicians trust.
Biostatira Research and Development Private Limited is a dedicated medical device company headquartered in India, committed to designing, developing, and delivering innovative biomedical solutions. Our multidisciplinary team of engineers, biomedical scientists, and clinical experts collaborate to address unmet diagnostic and therapeutic needs.
Our portfolio spans diagnostic imaging, point-of-care testing, therapeutic devices, and intelligent monitoring systems — each developed with clinical input and rigorous biocompatibility assessment.
High-resolution imaging platforms with AI-assisted analysis for early-stage pathology detection across radiology and cardiology workflows.
Class II DeviceRapid, accurate bedside diagnostic kits for biomarker detection — enabling faster clinical decisions in emergency and remote care settings.
In Vitro DiagnosticContinuous multi-parameter monitoring platforms with wireless data transmission, real-time alerts, and EHR integration for ICU and ward environments.
Active DeviceMinimally invasive therapeutic systems for targeted drug delivery and electrophysiological interventions designed to maximize efficacy and reduce side effects.
Class III DeviceNext-generation wearable biosensors for continuous glucose, cardiac rhythm, and neurological signal monitoring outside clinical settings.
Wearable / IoMTDeveloping biocompatible polymers, alloys, and surface coatings for implantable and contact devices. Our materials lab conducts cytotoxicity, sensitization, and hemocompatibility studies aligned with ISO 10993 standards.
Low-power embedded design for real-time biometric acquisition and processing. Research focuses on noise reduction algorithms, adaptive filtering, and ML-based artefact rejection for clinical-grade signal quality.
Rigorous clinical investigation protocols designed in partnership with leading hospitals. Our biostatistics unit powers study design, sample size estimation, and regulatory-grade statistical reporting for 510(k) and CDSCO submissions.
Integration of machine learning into diagnostic pipelines — from pathology image segmentation to predictive monitoring algorithms — validated on diverse Indian patient population datasets.
Cutting-edge research initiatives where biomedical engineering meets artificial intelligence — building tomorrow's diagnostic tools today.
"Every device we create carries the weight of a patient's trust. We engineer not merely to specification — but to conscience."
Whether you are a hospital group, a distribution partner, a research institution, or a regulatory body — we welcome collaboration that advances patient care.